Catalyst Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Catalyst Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Catalyst Pharmaceuticals (CPRX) Tops Q3 EPS by 2c, Offers FY19 and FY20 Guidance

November 12, 2019 4:41 PM EST

Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q3 EPS of $0.13, $0.02 better than the analyst estimate of $0.11. Revenue for the quarter came in at $30.9 million versus the consensus estimate of $33.18 million.

GUIDANCE:

Catalyst Pharmaceuticals sees FY2019 revenue of $100 million, versus the consensus of $111... More